|
[1]
|
Chinese Preventive Medicine Association, Vaccine and Immunology Branch of the Chinese Preventive Medicine Association. Expert consensus on the China pertussis initiative. Chin J Public Health 2021;42(6):955-65. http://dx.doi.org/10.3760/cma.j.cn112338-20210308-00186 (In Chinese). CrossRef
|
|
[2]
|
Chinese Center for Disease Control and Prevention. Pertussis. https://www.chinacdc.cn/nip/kpyd/xjxcrb/brkpsf/. [2022-12-6]. (In Chinese). https://www.chinacdc.cn/nip/kpyd/xjxcrb/brkpsf/ |
|
[3]
|
World Health Organization. Diphtheria tetanus toxoid and pertussis (DTP) vaccination coverage. https://immunizationdata.who.int/pages/coverage/dtp.html?CODE=CHN&ANTIGEN=&YEAR=. [2022-12-6].https://immunizationdata.who.int/pages/coverage/dtp.html?CODE=CHN&ANTIGEN=&YEAR= |
|
[4]
|
Ning GJ, Gao Y, Wu D, Li JH, Li YX, Shao ZJ, et al. Epidemiology of pertussis in China, 2011-2017. Chin J Vaccines Immun 2018;24(3):264-7,273. https://d.wanfangdata.com.cn/periodical/zgjhmy201803004. (In Chinese). https://d.wanfangdata.com.cn/periodical/zgjhmy201803004 |
|
[5]
|
Wang CL, Lü HY, Wang M. Effectiveness of diphtheria, tetanus and acellular pertussis combined vaccine against pertussis in <5-year-old children: a case-control study. Chin J Vaccines Immun 2019;25(5):528-31. http://qikan.cqvip.com/Qikan/Article/Detail?id=7100439971. (In Chinese). http://qikan.cqvip.com/Qikan/Article/Detail?id=7100439971 |
|
[6]
|
Li WH, Qiu CH, Peng YZ, Xie X, Cheng JQ, Huang F, et al. Effectiveness of pertussis vaccine among children 4 months to 6 years of age in Shenzhen City: a matched case-control study. Chin J Vaccines Immun 2022;28(5):525-8. http://dx.doi.org/10.19914/j.CJVI.2022100 (In Chinese). CrossRef
|
|
[7]
|
Wilkinson K, Righolt CH, Elliott LJ, Fanella S, Mahmud SM. Pertussis vaccine effectiveness and duration of protection - a systematic review and meta-analysis. Vaccine 2021;39(23):3120-30. http://dx.doi.org/10.1016/j.vaccine.2021.04.032CrossRef
|
|
[8]
|
Chong CY, Yung CF, Tan NWH, Acharyya S, Thoon KC. Risk factors of ICU or high dependency requirements amongst hospitalized pediatric pertussis cases: a 10 year retrospective series, Singapore. Vaccine 2017;35(47):6422-8. http://dx.doi.org/10.1016/j.vaccine.2017.09.085CrossRef
|
|
[9]
|
Mack I, Erlanger TE, Lang P, Sinniger P, Perisa D, Heininger U. Dose-dependent effectiveness of acellular pertussis vaccine in infants: a population-based case-control study. Vaccine 2020;38(6):1444-9. http://dx.doi.org/10.1016/j.vaccine.2019.11.069CrossRef
|
|
[10]
|
World Health Organization. The global vaccine action plan 2011-2020: review and lessons learned: strategic advisory group of experts on immunization. https://apps.who.int/iris/handle/10665/329097. [2022-12-8].https://apps.who.int/iris/handle/10665/329097 |
|
[11]
|
World Health Organization. Pertussis vaccines: WHO position paper, August 2015—recommendations. Vaccine 2016;34(12):1423-5. http://dx.doi.org/10.1016/j.vaccine.2015.10.136CrossRef
|